RATIONALE: During a smoking quit attempt, a single smoking lapse is highly predictive of future relapse. While several risk factors for a smoking lapse have been identified during clinical trials, a laboratory model of lapse was until recently unavailable and, therefore, it is unclear whether these characteristics also convey risk for lapse in a laboratory environment. OBJECTIVES: The primary study goal was to examine whether real-world risk factors of lapse are also predictive of smoking behavior in a laboratory model of smoking lapse. METHODS: After overnight abstinence, 77 smokers completed the McKee smoking lapse task, in which they were presented with the choice of smoking or delaying in exchange for monetary reinforcement. Primary outcome measures were the latency to initiate smoking behavior and the number of cigarettes smoked during the lapse. Several baseline measures of smoking behavior, mood, and individual traits were examined as predictive factors. RESULTS: Craving to relieve the discomfort of withdrawal, withdrawal severity, and tension level were negatively predictive of latency to smoke. In contrast, average number of cigarettes smoked per day, withdrawal severity, level of nicotine dependence, craving for the positive effects of smoking, and craving to relieve the discomfort of withdrawal were positively predictive of number of cigarettes smoked. CONCLUSIONS: The results suggest that real-world risk factors for smoking lapse are also predictive of smoking behavior in a laboratory model of lapse. Future studies using the McKee lapse task should account for between subject differences in the unique factors that independently predict each outcome measure.
RATIONALE: During a smoking quit attempt, a single smoking lapse is highly predictive of future relapse. While several risk factors for a smoking lapse have been identified during clinical trials, a laboratory model of lapse was until recently unavailable and, therefore, it is unclear whether these characteristics also convey risk for lapse in a laboratory environment. OBJECTIVES: The primary study goal was to examine whether real-world risk factors of lapse are also predictive of smoking behavior in a laboratory model of smoking lapse. METHODS: After overnight abstinence, 77 smokers completed the McKee smoking lapse task, in which they were presented with the choice of smoking or delaying in exchange for monetary reinforcement. Primary outcome measures were the latency to initiate smoking behavior and the number of cigarettes smoked during the lapse. Several baseline measures of smoking behavior, mood, and individual traits were examined as predictive factors. RESULTS: Craving to relieve the discomfort of withdrawal, withdrawal severity, and tension level were negatively predictive of latency to smoke. In contrast, average number of cigarettes smoked per day, withdrawal severity, level of nicotine dependence, craving for the positive effects of smoking, and craving to relieve the discomfort of withdrawal were positively predictive of number of cigarettes smoked. CONCLUSIONS: The results suggest that real-world risk factors for smoking lapse are also predictive of smoking behavior in a laboratory model of lapse. Future studies using the McKee lapse task should account for between subject differences in the unique factors that independently predict each outcome measure.
Authors: J K Ockene; K M Emmons; R J Mermelstein; K A Perkins; D S Bonollo; C C Voorhees; J F Hollis Journal: Health Psychol Date: 2000-01 Impact factor: 4.267
Authors: J R Hughes; S B Gulliver; J W Fenwick; W A Valliere; K Cruser; S Pepper; P Shea; L J Solomon; B S Flynn Journal: Health Psychol Date: 1992 Impact factor: 4.267
Authors: Sherry A McKee; Andrea H Weinberger; Julia Shi; Jeanette Tetrault; Sabrina Coppola Journal: Nicotine Tob Res Date: 2012-04-06 Impact factor: 4.244
Authors: Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves Journal: JAMA Date: 2006-07-05 Impact factor: 56.272
Authors: Maggie M Sweitzer; Charles F Geier; Merideth A Addicott; Rachel Denlinger; Bethany R Raiff; Jesse Dallery; F Joseph McClernon; Eric C Donny Journal: Neuropsychopharmacology Date: 2016-04-19 Impact factor: 7.853
Authors: Amanda R Mathew; Bryan W Heckman; Brett Froeliger; Michael E Saladin; Richard A Brown; Brian Hitsman; Matthew J Carpenter Journal: Exp Clin Psychopharmacol Date: 2018-12-27 Impact factor: 3.157
Authors: Mary Falcone; Leah Bernardo; E Paul Wileyto; Cheyenne Allenby; Anne Marie Burke; Roy Hamilton; Mario Cristancho; Rebecca L Ashare; James Loughead; Caryn Lerman Journal: Drug Alcohol Depend Date: 2018-11-13 Impact factor: 4.492
Authors: Bryan W Heckman; David A MacQueen; Nicole S Marquinez; James MacKillop; Warren K Bickel; Thomas H Brandon Journal: J Consult Clin Psychol Date: 2017-04